Member Info for George-Inn

Looking at the three components of the most recent combined funding you have the following: (Combined China investment of 8 mil) (the placing of 4.7 mil in which Woodford participated to keep 20% of the company) and now you have an opportunity to secure another 800k by placing 20 million more shares at 0.318 and reward the new shareholders with a free warrant exercisable at 50p. What about loyal shareholders whom have contributed to keeping your company going for the past three years? Where's my warrant(s)? I guess I only get them if I contribute more like Woodford. Well prior to the most recent Open offer the company has leveraged about 85% of their distributable shares and after this tranche of 20 mil used for the open depending on the take up of, the company will be leveraged nearly 100% no more shares can be distributed and that means likely they'll do a stock merger of some sort to reduce the share count, artificially raise the S/P and meet the Nasdaq rules in April. That won't help anyone except the shorts, as they'll beat it down over the two years while the trials progress. Further I'm glad to see woodford keep his 20% ownership and invest a couple of million more into the venture, finally I will say to N2MU that you're probably right about one thing and wrong about another. You're probably right in the assertion of the smugness, and it's because of the smugness and length of time taken to prove out the theory that will cause them NOT to sell out at the first few hundred million offer as once they prove this out then they'll be more smug and awaiting the higher eight figure offer's. Nothing less will do as they have an ego, and they owe it to the II's and PI's plus themselves and listen I hope they do prove it out and I hope that they do get their eight figure offer as it will only help me more. We should have a darn god read out on this theory in about 18 months or so. Just my thoughts but I bet they won't be taken out for a couple of hundred like you say because it's not worth it and that's one reason they're not allowing the Chinese to have more than 50% ownership. Somewhere down the road if and when this proves out some company will have to step up to take this out, and it's likely because of the mgt (attitude) that comes with being right after so many years. So in a way I agree in part with your assessment....GLTU N2MU and all other investors here. I'll be doing my part to take up my portion of that offering, but really what I want to know is where are my warrants today? ha ha ha ....

Best news here yet

( The Directors estimate that the trial cost for MTD201 will be approximately £5 million to £7 million; on Admission the Directors have agreed such funds will be segregated into an account to be held specifically to fund the trial)

I'm continuing to buy tranches where and when possible...I will take up some at the offering also.. N2MU (Never is a long, long time) you're entitled to your own opinion, lord knows we all have one. GLTA

If you look back at the mid and annual updates H2 2017 and forward they've the management team have had great liquidity. Looks like north of 40 mil and then it evaporated. In addition there was a raise in 2017 that netted funds, sale of MTPUS that netted funds, grants as well as infusion from the likes of L&G and now China investment and a separated raise which we've yet to see the depth of. When I go back and look at the accomplishment or activities that took place from all of that infusion of cash it's merely the 201 and 110 programmes which the 110 is not completed and the 201 was mainly a live test in humans but yeilded no FDA results. Now the China infusion is merely to pad the payroll and operations for 2019 so where is the funding coming from to complete the next phase of the 201 programme and ramping up the factory? I mean over the past two years 40 million plus has been on hand the way I count it. Even more dire is just a few months out the listing on the nasdaq comes due and my suspicions re that with the artificial flood of shares more than 103 million per chinese investor plus a raise along side that may put the share count upaward of 400 or 500 million shares. Where today we're about 67 million or so, and in order to remain listed the S/P must be $1 or else you delist or correct the deficiency to stay listed, basically a reverse split to artificially prop up the share price. Thats not going to help anyone without results and will only embolden the shorts to know it down plus the split would be massive to get the share count back down to reasonable levels... All just my opinion and hunches, but unless the management team has a zinger of a news release or campaign readied to up the SP then I don't know what they plan to do but we'll see. Any other thoughts here on the matter are welcome. I believe in the technology, the management team, the good that the products will or could do to extend or save lives and the fact that management and board have off-loaded the losing piece of the business, to stablize the company, but dire times are here and this company needs a fair tranche of funding to get the next clinicals done and ramp the Bilboa factory get NDA submitted and a little house cleaning is in order for the nasdaq somehow to stay listed in the states. Indeed dire times are here and me fingers are crossed.

Indeed SilverK....indeed. That is about the gist of it.

SilverK - i'd caveat the phrase more as (Critical Times Ahead I Think ) Look desperation to secure funding that's just unfortunate to end up in that predicament. The Chinese deal appears as 77% on share value and paper only. They don't really own in total and couldn't own the company for 5p as I've stated there is real-estate, patents, IP and infrastructure, trademark products and other hidden softcost which put the company's true value far greater than the S/P times the available lot. Regarding these critical times ahead once the special meeting and vote is over and the deposit is made to float the operations and payroll moving forward, what we need to see next are RESULTS.. Pure and simple. Not kicking the can down the road, not pushing out the delivery dates on NDA's and not providing continued excuses for failing to deliver. You want to keep shareholders enthusiastic ?? You want additional funding from new shareholders?? well there's a sure-fire way to get it....and that is (Deliver on Results...Plain and Simple).
Just my own opinion and my own thoughts on this bitter cold and snow day. I'll be ready for me pint's o' stout and me F/C's in a couple more hours and maybe me mood will swing to a better state.... GLTA

Next few weeks are going to be very interesting and also to see what additional news is released. There should be a circular regarding the upcoming special vote for the Chinese venture. There should also be news released about H2 earnings and/or Yr Results. Somewhere in these RNS there has to be mention of corporate conference call and presentation to update investors as well as mention the continuation and expectation of Nasdaq listing in the U.S.

The chaps over the pond trade the ADR's and In order for an ADR to list on an American exchange, the company it represents must meet all the typical NYSE or Nasdaq SEC disclosure requirements. That means reporting H2 and YR Results plus there are about 3 mos left in order to get the S/P above minimum bid of $1 for 10 consecutive trading days. This is a lot of information to flow release over the coming weeks, and if the listing is to remain on Nasdaq as assume they would desire as the states are a large market. Then there may either be some promotional news needing to be released to drive the S/P upward or the share base will have to consolidate to absorb a Reverse Split which is certainly not my desire as a shareholder and probably not good. All just my 2 cents worth, my own speculation and observance. Please do your own review and research, in light of these possibilities I'm not certain that I will add any additional shares further as the reality of a reverse split only sets the stage for shorts to knock it back down while we await the clinical results to come in opening the door to further losses. My hopes are that the company has worthy news that can be released and Panmure and others can prop up the S/P to regain that listing compliance in the states or else I fear consolidation. Again all my 2 cents worth, and speculative.

NtoMu - It's probably true that the management consulted with other II's as part of the strategic direction and terms with the new Chinese firms. A couple of interesting notes to take away from this China venture and before the special shareholders meeting to vote. And the first is from the article ( Pursuant to the Licence Agreement, the licensees will be responsible for funding the development and commercialisation of the Group's product) So that would mean that in addition to MTX201 the Chinese will likely use the Q-Spera technology to potentially develop other drugs. Quite interesting enough is the fact that this Chinese co. is a powerhouse in the Chinese market area and has both "promotional and advertising" capabilities. That will be interesting to see how they plan to deliver on those capabilities over the coming months. Secondly with all of these new shares being listed or sold that artificially floods the current Tranche of shares and yes dilutes the common shares. I suspect with the Nasdaq listing in the states coming due 4/29/19 that the company will look at whether it can either bring the price up on some news to secure the listing or else have to look at the potential for a reverse split if they desire to retain their listing. This of course would be bad for all investors as it will greatly diminish the amount of common shares available, unless that is there intent. By issuing this amount of shares it shifts the balance of ownership of the II's like Woodford and L&G. I'd be very surprised if they elect not to participate in a meaningful way as you suggested which I hope is not the case. Now we have to focus on whether the company can get the share price high enough to allow the continual listing of the Nasdaq and or if Nick and the board elect the Hong Kong market for a mutual listing as well. An R/S to retain the listing will greatly diminish the shares once again if that were to occur.

The company now has a clear path from the regulators and after 5 years of development there is one final clinical trial needed before submission for marketing approval. (IF) approved by regulators several doors open up. Midatech partners and markets the drugs in multiple markets, entertains a buyout , entertains other options.

They will achieve funding in my opinion as a few million in loans to see how this final clinical trial plays out is simply the small price to pay to see the results. The results could be a fair sized piece of the multi-billion market and that alone is worth the price of admission. It's my honest opinion that they'll secure funding as we're near the finish line and someone will want to see those final results. I will be adding more shares next week, right or wrong I'm increasing the tranche. GLTA other investors and gamblers.

I've not much to add here discussion wise, save for the clarity from the FDA now lay's out the strategic path forward. My hunch is simple and that is hopefully MTPH will secure the funding, see the product trials through to NDA and get approval from FDA. it may take many months but if interim positive news of success for the MTD201 were to occur then S/P could rise and other big-pharma to throw bid at it. I mean there are literally half dozen scenarios from here that could unfold. Question is how much stomach does it take to add more here today? I just did add more and now my tranche of shares is even bigger. There are two certainties here (1) I will either end up rich/poor and the other certainty is that I will be having multiple pints of beer later today with me F&C's...GLTA

Those big blocks being snatched up aren't being done so without good cause and its my speculation that the selling may be over. Selling big blocks seems to have given way to buying them, as for the FDA concerns it's my hunch that the FDA is busy working on the matters currently in their pipeline for review and response. We should be getting news most any day this week or next, no worries from my point of view. I'm going to add more this Friday if it presents a good opportunity. GLTA

The 5p price is just too good to leave on the table. Besides I believe that news is forthcoming next week or two regarding updates to funding, partnering and possibly FDA direction. It's my belief that 5p will be short lived and I want to load more while I can. All just my personal opinion, good luck to all. In a couple of more hours it will be time to head down and across the street to a couple of pints and F&C's. Hope we get some news....

Harry & Silly, what's occured here now as of the the L&G RNS is fairly common when a controlling interest in a single stock has been given up. In total based on either the common or select shares then the following has occured. Single shareholders with as little as 5-10 percent ownership like L&G used to have can push for their own seats on the board or enact changes at shareholder meetings by publicly lobbying for them, giving them control.

My hunch is fairly simple and that is that the management at Midatech probably didn't want this much power (other than Woodford) to be held by another investment firm. My hunch is that current management is positioning or steering the company in another direction openeing the door for other partners, and opportunities for bigger pharma players. Much like the divorce and sale of the MTPUS portion opened the door for changes in the whole direction of the company, a divorce of L&G or reduction in their share count would force them to give up voting seats and the right to place a person on the BOD and/or lobby for directional change. No in my opionion this new Midatech managment team has a specific direction that they desire to head in and with L&G now or very soon effectively removed from voiting rights the curtrent management can open the company to a number of new partnership or potential sale opportunities without a proxy like L&G having thier hands in the ultimate say so. Woodford I beleive is in a passive investor seat and although he owns a mound of shares he's passive in the daily doings and direction of the company. All just my two cents worth and based only on my observations and understanding of the current matter. GLTA and please do your own research, but I am satisfied with my own, and now with L&G nearly out of the way the management can soon act., again my two cents and just my hunch...

Whomever is saying two U.S. shares equals one AIM is totally incorrect. To be clear and factual over the pond in the U.S the MTP hares are listed as an ADR or American Depository Receipt. This is an easy way for the states to trade foreign stocks and the ratio of ADR's varies. In the case of Midatech the ratio is that two (2) common listed AIM shares equals one (1) ADR. So to be crystal clear it's ONE U.S. ADR share equals TWO of our AIM shares. this is fact.

Ask now 17p so their early trading ahead of the market open can begin at 11:30 and then those with L2 can see any pre-market open trades over there. GLTA I've got to admit this is the most posts I've seen here in 6 mos. I will continue to accumulate and build on an already enormous amount of shares. Pints for certain later today...

Midatech announces EUR 1.5 million loan facility for manufacturing site

- Basque Regional Government approves loan facility to support manufacturing facility in Bilbao

- Funds to be used as part of commercial scale up for MTD201 and Q-Sphera™ platform

Nope just looking at the ask over there that's all.... Assume it could change no doubt but as is showing 25p on there L2

Looks like early trading ask on Naz is 25p and therefore stateside looks like a runner again setting up. Early pints for me today just downstairs and across the street are some fine stouts...

It's my hunch or suspicion that an RNS is in the making. Would like to see an update this week either partnership update, funding or H2 update. It's a bit quiet and I need a good reason to head down later this week for a couple pints of stout. Glta

Volume in the states is over five times normal and it's still few hours of trading left. I suspect another RNS will be released in coming days regarding the partnership, secured funding or equity raise vote or something. I'm not now and have not been worried, but very happy to see all of the good read out of these updates. I continued buying into year-end, will add a wee bit more this month and then see where we go. I would hope that over the next 18 - 24 months the SP appreciates unbelievably, we shall see. Good Luck All.....

An update regarding a potential partnership or even buyout is also possible. More importantly is an update on clinical progress. Unlike others I do see a need or rather let's say I'm compelled to buy more now before NY as likely by then the window of opportunity to get these 6p and 7p prices will be vanished. Just my opinion....glta